NeoSensory, Inc.
NeoSensory, Inc. is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at NeoSensory, Inc..
NeoSensory, Inc. is a company.
Key people at NeoSensory, Inc..
NeoSensory, Inc. develops wearable wristband devices that translate sound into haptic vibrations, enabling sensory augmentation for people with hearing loss, tinnitus, and profound deafness. The company targets individuals with moderate-to-severe auditory challenges, offering products like Clarify, Duo, and Sound Awareness to improve speech comprehension, tinnitus management, and environmental awareness through non-invasive brain-machine interfaces.[1][3] Founded in 2015 and headquartered in Palo Alto or nearby areas in California (with some references to Houston and San Mateo), NeoSensory reports around $5.6 million in revenue, 23-28 employees, and an estimated enterprise valuation of $40-60 million as of 2019, showing steady growth in the deep tech wearables space.[2][3][4]
NeoSensory emerged from neuroscience research, with roots in Stanford-affiliated work by neuroscientists like David Eagleman, known for early haptic projects such as the Eagleman Vest.[1][4] Founded in 2015, the company was inspired by the need for alternatives to traditional hearing aids, particularly for high-frequency hearing loss and tinnitus, where conventional solutions fall short.[3] Early traction came from patented wristband technology backed by scientific studies, evolving from prototypes to award-winning products like Clarify, which launched as a breakthrough in audiology by converting speech vibrations to skin sensations.[1][3] Pivotal moments include clinical adoption and recognition for redefining accessibility through touch-based "new senses."[1][2]
NeoSensory rides the wave of neurotechnology and sensory substitution, part of a boom in brain-computer interfaces (BCIs), haptics, and wearables addressing accessibility in an aging population with rising hearing impairments.[1] Timing aligns with advances in AI-driven signal processing and deep tech hardware, fueled by market forces like post-pandemic telehealth demand and $multi-billion audiology markets underserved by hearing aids (which help only ~20% of severe cases).[3] It influences the ecosystem by pioneering haptic "sixth senses," inspiring BCI peers in motor restoration and neuromedicine, and expanding human-machine interaction for disabilities—potentially scaling to AR/VR enhancements or cognitive tools.[1][2]
NeoSensory is poised for expansion through product iterations, clinical partnerships, and B2B growth in rehab/IoT, leveraging its $40-60M valuation for funding rounds amid neurotech hype.[2][4] Trends like AI-optimized haptics, aging demographics, and FDA nods for wearables will propel it, potentially capturing share in the $10B+ hearing aid market with superior efficacy for untreatable cases.[3] Its influence may evolve from niche accessibility to mainstream sensory tech, redefining quality of life via touch and paving ways for broader BCI adoption—building on its mission to expand human perception.[1]
Key people at NeoSensory, Inc..
